
What is Mavyret?
Mavyret (Glecaprevir/Pibrentasvir) is an oral, fixed-dose combination antiviral approved for treating chronic hepatitis C in adults and children aged 3 and above. Hepatitis C is liver inflammation caused by a virus, leading to acute or chronic hepatitis. The condition ranges from mild to severe, potentially causing liver cirrhosis and cancer.
Mavyret is effective against all six major HCV genotypes (1 through 6) and can be used in patients without cirrhosis or with compensated cirrhosis (Child-Pugh A).
It is also used for people with HCV genotype 1 who have been treated before with certain other HCV medications. Mavyret contains two active ingredients: glecaprevir and pibrentasvir.
It is not known if Mavyret is safe and effective for children under 3 years old. Before taking Mavyret, tell your doctor about any other medical conditions, including:
- If you have had hepatitis B,
- Liver problems,
- HIV-1,
- Pregnant, planning to become pregnant, or breastfeeding
- If you are taking these medications: atazanavir or rifampin
Mavyret can reactivate hepatitis B, which can cause serious liver problems. Do not take Mavyret if you have certain liver problems or are taking the medicines atazanavir or rifampin.
How Does Mavyret Work?
Mavyret targets the hepatitis C virus directly to prevent its multiplication. It comprises glecaprevir and pibrentasvir.
Pibrentasvir blocks a key protein called NS5A needed for viral replication. Glecaprevir acts on another protein, NS3/4A, crucial for virus growth and spread in cells.
By blocking these viral proteins, Mavyret prevents the hepatitis C virus from multiplying. Over the course of treatment, this suppression allows the immune system and liver to clear the infection, often resulting in a sustained virologic response (SVR), which is considered a cure.
Dosage Information and Usage
Dosage Form and Strengths
Mavyret is available in two forms for oral use: tablets and pellets.
The tablets are pink, oblong-shaped, and have “NXT” marked on one side. Each tablet contains 100 mg of glecaprevir and 40 mg of pibrentasvir.
The oral pellets are pink and yellow and come in packets. Each packet contains 50 mg of glecaprevir and 20 mg of pibrentasvir.
Usage
Before starting Mavyret, your doctor will test you for hepatitis B to prevent complications. The dosage of Mavyret varies based on the patient’s age, weight, and whether they have liver scarring.
Adults and adolescents weighing at least 45 kg usually take three tablets once daily with food, for a treatment duration of 8 to 16 weeks, depending on prior treatment history and presence of cirrhosis. For children under 12 or weighing less than 45 kg, the dose is given as oral pellets based on their weight.
Do not change or stop your dose without consulting your doctor. If you miss a dose, take it as soon as possible if it’s within 18 hours. If more than 18 hours have passed, skip the missed dose and take the next dose at the usual time with food.
Side Effects
Common Side Effects
- Headache
- Tiredness
Serious but Rare Side Effects
In people with advanced liver problems, before starting Mavyret, there is a rare risk of:
- Worsening liver problems
- Liver failure
- Death
Contact your doctor immediately if you experience:
- Nausea
- Extreme tiredness
- Yellowing of your skin or eyes
- Easy bleeding or bruising
- Confusion
- Dark, black, or bloody stool
- Loss of appetite
- Diarrhea
- Dark or brown urine
- Swelling or pain in the upper right side of your abdomen
- Sleepiness
- Vomiting blood
- Lightheadedness
Warnings and Precautions
- Risk of Hepatitis B Virus Reactivation in Patients Coinfected with HCV and HBV: Patients with both hepatitis C virus (HCV) and hepatitis B virus (HBV) infections may see HBV reactivation during or after using Mavyret. This can cause serious liver issues like failure and death. Reactivation shows a sudden rise in HBV replication, seen with higher HBV DNA levels in the blood. Even patients with past HBV infection (HBsAg negative and anti-HBc positive) can have reactivation.
- Risk of Hepatic Decompensation/Failure in Patients with Advanced Liver Disease Evidence: Some patients with advanced liver disease, like cirrhosis or severe liver impairment (Child-Pugh B or C), may face liver decompensation or failure with Mavyret. This can lead to serious outcomes, including death. Decompensation may manifest shortly after starting treatment as jaundice, abdominal fluid buildup (ascites), confusion, or bleeding from enlarged esophageal veins (variceal hemorrhage).
- Risk of Reduced Therapeutic Effect Due to Concurrent Use with Specific Medications: Taking Mavyret with drugs such as carbamazepine, efavirenz, or St. John’s wort can decrease glecaprevir and pibrentasvir levels in the blood, reducing Mavyret’s effectiveness against HCV. It’s advised not to use these medications together to maintain Mavyret’s efficacy.
Overdosage
If someone takes too much Mavyret, they should be closely watched for signs of possible side effects. Immediate treatment should be provided to manage any symptoms that occur. Hemodialysis, a process to remove substances from the blood, does not effectively remove glecaprevir and pibrentasvir from the body in case of overdose.
Drug Interactions With Other Medications
- Mavyret’s Effect on Other Drugs: Mavyret can influence how other drugs are processed in the body. It inhibits proteins like P-glycoprotein (P-gp), breast cancer resistance protein (BCRP), and organic anion transporting polypeptide (OATP) 1B1/3, which are responsible for moving drugs in and out of cells. When these proteins are blocked, other drugs that rely on them might stay in the body longer, possibly boosting their effects.
- Effect of Other Drugs on Mavyret: Drugs that either speed up or slow down the activity of P-gp, BCRP, or OATP1B1/3 can impact how Mavyret works in your body. For example, drugs that boost these proteins can lower Mavyret levels in the bloodstream, which might reduce its effectiveness against hepatitis C.
- Specific Drug Interactions to Note: Certain medications like carbamazepine (used for seizures), phenytoin (also for seizures), efavirenz (for HIV), and St. John’s Wort (a herbal supplement) can lower Mavyret levels. This reduction may make Mavyret less effective in treating hepatitis C.
- Medication-assisted treatment (MAT) for Opioid Use Disorder: Mavyret doesn’t need dose adjustments when taken with medications like buprenorphine/naloxone or methadone for opioid addiction treatment. However, there’s not enough data to confidently recommend using naltrexone with Mavyret.
- Drugs with No Clinically Significant Interactions: Many medications, including abacavir (for HIV), caffeine, lamotrigine (for seizures), and others, do not affect Mavyret’s effectiveness and can be safely used together without needing dose adjustments.
Cost & Discounts
Your health is a priority, and getting the necessary medication shouldn’t be a financial burden. Dedicated to making healthcare both affordable and accessible, Pharma Giant ensures you don’t have to compromise on your well-being.
We offer 100mg/40mg packs with 84 tablets available for $30,600.00.
At Pharma Giant, we provide quality medication at prices that won’t break the bank. Choosing Pharma Giant means you can manage your health effectively and affordably.
Special Discount on Mavyret
Take advantage of Pharma Giant’s exclusive discount to save on your medication costs.
Use the code [code] at checkout to receive a 10% discount on your Mavyret purchase.
This limited-time offer ensures that you get essential healthcare products at a more affordable rate without compromising on quality.
This offer is for one-time use per customer and won’t last long.
Superior Quality and Prompt Delivery
At Pharma Giant, we are committed to providing exceptional medication quality and expedient delivery to your doorsteps.
Our express shipping guarantees that your orders will arrive within 3-5 business days across the United States, securely packaged to ensure the integrity of your medication during transit.
Pharma Giant takes pride in our commitment to reliable, efficient, and timely service for all our customers.
Frequently Asked Questions
Disclaimer
Pharma Giant provides medical information to help you better understand medications and medical conditions.This content is for informational use only and does not replace advice from a licensed medical practitioner. Consult your doctor or pharmacist before starting or changing any medication. All our partners follow strict safety standards set by their country’s health authorities to make sure you receive safe and high-quality medications.






